Stockreport

Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]

BioNTech SE - American Depositary Shares  (BNTX) 
PDF Pipeline additions with multiple KRAS neoantigen targets Advancement of lead program MDG1015 with IND/CTA approval expected in 2H 2024 Partnering expansion with new [Read more]